about
Elucidation of the mTOR Pathway and Therapeutic Applications in Dermatology.Dermatofibrosarcoma protuberans with fibrosarcomatous transformation.Alemtuzumab in refractory Sézary syndrome.Linear basal cell carcinoma: Report of three cases with dermoscopic findings.Ingenol mebutate for the treatment of actinic keratosis: effectiveness and safety in 246 patients treated in real-life clinical practice.Imiquimoid 5%: In Pursuit of New Treatment Regimens for Actinic Keratosis.Superimposed lateralized exanthem in a 30-year-old woman.Topical Amphotericin B for the treatment of localized cutaneous leishmaniasis.Otophyma: a rare variant of phymatous rosacea.Eslicarbazepine-induced toxic epidermal necrolysis.Asymptomatic angiomatous lesions on the face and limbs of an adult woman.Facial Angiofibroma Severity Index (FASI): reliability assessment of a new tool developed to measure severity and responsiveness to therapy in tuberous sclerosis-associated facial angiofibroma.Neoadjuvant intralesional methotrexate in cutaneous squamous cell carcinoma: a comparative cohort study.Imatinib treatment of therapy resistant generalized deep morphea.Subcutaneous phaeohyphomycosis due to Alternaria infectoria in a renal transplant patient: surgical treatment with no long-term relapse[Topical sirolimus 0.4% formulation for treatment of facial angiofibromas]Neoadjuvant intralesional methotrexate before surgical treatment of invasive squamous cell carcinoma of the lower lipRenbök phenomenon in a patient with alopecia areata universalisBeard involvement in a man with frontal fibrosing alopeciaClassic Kaposi's sarcoma treated with topical 0.5% timolol gelDome-shaped nodules and scaly, verruciform plaques on the legs and feetLocalized Acral Sclerosing Langerhans Cell Histiocytosis: A New Form of Presentation of Cutaneous Langerhans Cell HistiocytosisEfficacy of an Innovative Film-Forming Wound Dressing on Open WoundsMerkel-Cell CarcinomaCombined daylight and conventional photodynamic therapy with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis of the face and scalp: a new and efficient approachAre Additional Tests Indicated in Ambulatory Dermatologic Surgery?[The perception of care received by patients with actinic keratosis]
P50
Q38723844-D5EA4E19-B3FE-4763-BB9A-7CB97CBB08B9Q42377622-5E3A7493-C4ED-4981-83C7-18BA1014A523Q42377651-3F92E73C-23CB-446C-BD40-A0755DD7C4F2Q42499173-739E402E-C350-40A2-8B82-C0AC0193AA20Q47626283-BA56051C-991E-4369-A433-A66C6152B546Q50024325-C18C6E68-0F2C-4C5E-970D-72361B77EC83Q50146849-1C772452-CEDB-4363-8897-657073F12D90Q51806710-394C0225-AC93-4090-9184-9F6BC1978922Q53101110-33320F63-21AD-4191-86B1-15BEF9550DDFQ53105137-303CA449-EE69-4D72-A3CC-F3FCE00C5B65Q53120024-73052D19-DB88-44EB-A9DD-0FA59F5386D3Q53152173-D8C6823B-C300-4BE9-847C-25A37893C001Q53351285-1304F87C-FE87-4690-98CD-EB549FA5AD9AQ53484390-046B9BF7-B778-4E2D-8273-2068F799F6F7Q84539433-16FB1F80-11FD-4B28-8C08-55C3223582EBQ84712283-E6DE1689-ED62-4F47-80FC-9724DEFB1693Q84723221-AFE1F625-0892-4EC4-B8D9-E2DC82298187Q84842328-47DF329C-1AD3-42B6-AB60-B2304797342EQ85933979-AD2FE8A1-1873-4FEE-9B1D-F7694296DB75Q87721480-DD74778D-48EB-4C22-9335-97AAF3BA776FQ88273010-CB4BF0DF-93B8-4FA7-A337-8C9E24FA3BDBQ91279128-DF500DF2-4E91-45B8-A11B-FA96062AB706Q91544472-AFC22625-800B-4FEF-B618-85EBE982C814Q91691083-A9481946-F90E-4B7D-AEA6-CE7D53AC1DCCQ91985157-5DBF3F5C-DA95-4DA6-AC6A-33909556933EQ92168020-06FBEC5A-F5AC-4C57-A8F5-FCE9174F1554Q93375890-93C8ADE7-E358-48FD-8A41-2FB5A1042358
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
R Salido-Vallejo
@en
R Salido-Vallejo
@nl
type
label
R Salido-Vallejo
@en
R Salido-Vallejo
@nl
prefLabel
R Salido-Vallejo
@en
R Salido-Vallejo
@nl
P31
P496
0000-0001-7210-8959